Published in J Natl Compr Canc Netw on September 01, 2009
Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare. J Clin Oncol (2012) 2.00
International preoperative rectal cancer management: staging, neoadjuvant treatment, and impact of multidisciplinary teams. World J Surg (2010) 1.62
Positive lymph node retrieval ratio optimises patient staging in colorectal cancer. Br J Cancer (2009) 1.32
Survivorship care planning in colorectal cancer: feedback from survivors & providers. J Psychosoc Oncol (2012) 1.11
KRAS mutation testing in metastatic colorectal cancer. World J Gastroenterol (2012) 1.11
Laparoscopic-assisted versus open surgery for rectal cancer: a meta-analysis of randomized controlled trials on oncologic adequacy of resection and long-term oncologic outcomes. Int J Colorectal Dis (2010) 1.06
A systematic review of treatment guidelines for metastatic colorectal cancer. Colorectal Dis (2012) 1.02
Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol (2011) 1.01
The current landscape of locally advanced rectal cancer. Nat Rev Clin Oncol (2011) 0.99
Transanal TATA/TME: a case-matched study of taTME versus laparoscopic TME surgery for rectal cancer. Tech Coloproctol (2016) 0.99
The dynamics of colorectal cancer management in 17 countries. Eur J Health Econ (2010) 0.96
Tumor board participation among physicians caring for patients with lung or colorectal cancer. J Oncol Pract (2015) 0.95
Transportation: a vehicle or roadblock to cancer care for VA patients with colorectal cancer? Clin Colorectal Cancer (2011) 0.94
Post-treatment surveillance in colorectal cancer. Radiol Oncol (2010) 0.94
Management of stage IV rectal cancer: palliative options. World J Gastroenterol (2011) 0.93
Quality of cancer care among foreign-born and US-born patients with lung or colorectal cancer. Cancer (2010) 0.92
Lymph node count after preoperative radiotherapy is an independently prognostic factor for pathologically lymph node-negative patients with rectal cancer. Medicine (Baltimore) (2015) 0.91
Neoadjuvant radiotherapy for rectal cancer: adherence to evidence-based guidelines in clinical practice. World J Surg (2013) 0.90
A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer. BMC Cancer (2014) 0.90
Minimally invasive surgery for rectal cancer: are we there yet? World J Gastroenterol (2011) 0.89
Liver resection for colorectal cancer metastases. Curr Oncol (2013) 0.89
Prognostic impact of the metastatic lymph node ratio on survival in rectal cancer. Ann Coloproctol (2013) 0.87
The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease. World J Surg Oncol (2012) 0.86
American Cancer Society Colorectal Cancer Survivorship Care Guidelines. CA Cancer J Clin (2015) 0.86
Pathologic predictive factors for lymph node metastasis in submucosal invasive (T1) colorectal cancer: a systematic review and meta-analysis. Surg Endosc (2013) 0.86
Role of miR-100 in the radioresistance of colorectal cancer cells. Am J Cancer Res (2015) 0.84
Local excision for early rectal cancer: transanal endoscopic microsurgery and beyond. J Gastrointest Oncol (2015) 0.83
Helical tomotherapy combined with capecitabine in the preoperative treatment of locally advanced rectal cancer. Biomed Res Int (2014) 0.83
Oncologists' experiences with drug shortages. J Oncol Pract (2014) 0.83
Tailored selection of the interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer: analysis based on the pathologic stage or chemoradiation response. J Cancer Res Clin Oncol (2014) 0.83
Improved outcomes of colorectal cancer patients with liver metastases in the era of the multidisciplinary teams. Int J Colorectal Dis (2015) 0.83
When is local excision appropriate for "early" rectal cancer? Surg Today (2013) 0.83
Patterns of Pelvic Radiotherapy in Patients with Stage II/III Rectal Cancer. J Cancer Epidemiol (2013) 0.82
Capecitabine in the management of colorectal cancer. Cancer Manag Res (2011) 0.81
Identification of risk factors for recurrence in high-risk stage II colon cancer. Int Surg (2013) 0.81
Prognostic significance and molecular mechanism of ATP-binding cassette subfamily C member 4 in resistance to neoadjuvant radiotherapy of locally advanced rectal carcinoma. PLoS One (2014) 0.81
Feasibility of mesorectal vascular invasion in predicting early distant metastasis in patients with stage T3 rectal cancer based on rectal MRI. Eur Radiol (2015) 0.80
Invasive procedures in the elderly after stage IV cancer diagnosis. J Surg Res (2014) 0.80
Racial and ethnic disparities in outcomes with radiation therapy for rectal adenocarcinoma. Int J Colorectal Dis (2011) 0.80
Selective use of adjuvant chemotherapy for rectal cancer patients with ypN0. Int J Colorectal Dis (2014) 0.80
Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol (2012) 0.80
The Role of Robotic Surgery for Rectal Cancer: Overcoming Technical Challenges in Laparoscopic Surgery by Advanced Techniques. J Korean Med Sci (2015) 0.79
A simulation model of colorectal cancer surveillance and recurrence. BMC Med Inform Decis Mak (2014) 0.79
General aspects of colorectal cancer. ISRN Oncol (2012) 0.79
Optimal delivery of colorectal cancer follow-up care: improving patient outcomes. Patient Relat Outcome Meas (2015) 0.79
Physicians' beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer. J Oncol Pract (2014) 0.78
Preoperative radiotherapy for rectal cancer: a comparative study of quality control adherence at two cancer hospitals in Spain and Poland. Radiol Oncol (2014) 0.78
Predictors of Long-Term Quality of Life for Survivors of Stage II/III Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium. J Oncol Pract (2015) 0.78
Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer. Oncotarget (2014) 0.78
A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas. Int J Surg Oncol (2012) 0.78
Impression of prognosis regarding pathologic stage after preoperative chemoradiotherapy in rectal cancer. World J Gastroenterol (2015) 0.78
Extended RAS testing in metastatic colorectal cancer-Refining the predictive molecular biomarkers. J Gastrointest Oncol (2015) 0.78
Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis. PLoS One (2015) 0.77
Chemoradiotherapy and concurrent radiofrequency thermal therapy to treat primary rectal cancer and prediction of treatment responses. Oncol Rep (2016) 0.77
Rectal cancer: An evidence-based update for primary care providers. World J Gastroenterol (2015) 0.77
A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer. Clin Transl Oncol (2012) 0.77
Utility of EUS following endoscopic polypectomy of high-risk rectosigmoid lesions. Endosc Ultrasound (2015) 0.77
The management of rectal cancer with synchronous liver metastases: a modern surgical dilemma. Tech Coloproctol (2012) 0.77
Is It Possible to Shorten the Duration of Adjuvant Chemotherapy for Locally Advanced Rectal Cancer? Medicine (Baltimore) (2016) 0.77
KRAS Mutation Status Is Not a Predictor for Tumor Response and Survival in Rectal Cancer Patients Who Received Preoperative Radiotherapy With 5-Fluoropyrimidine Followed by Curative Surgery. Medicine (Baltimore) (2015) 0.77
Does geography influence the treatment and outcomes of colorectal cancer? A population-based analysis. World J Surg Oncol (2013) 0.77
Recently published indicators allow for comparison of radiation treatment rates relative to evidence-based guidelines for rectal cancer. Curr Oncol (2012) 0.77
Prospective analysis of 18F-FDG PET/CT predictive value in patients with low rectal cancer treated with neoadjuvant chemoradiotherapy and conservative surgery. Biomed Res Int (2014) 0.77
Preoperative chemoradiation and extended pelvic lymphadenectomy for rectal cancer: Two distinct principles. World J Gastrointest Surg (2010) 0.77
Current evidence-based opinions in the management of adenocarcionoma of the rectum. Indian J Surg (2010) 0.76
Positive peritoneal washing cytology is a potential risk factor for the recurrence of curatively resected colorectal cancer. Surg Today (2013) 0.76
Hospital variation in sphincter preservation for elderly rectal cancer patients. J Surg Res (2014) 0.75
Successful Treatment of Metastatic Anal Canal Adenocarcinoma with mFOLFOX6 + Bevacizumab. Case Rep Oncol (2016) 0.75
Anorectal Cancer: Critical Anatomic and Staging Distinctions That Affect Use of Radiation Therapy. Radiographics (2015) 0.75
A retrospective chart review validates indicator results and provides insight into reasons for non-concordance with evidence-based guidelines. Curr Oncol (2012) 0.75
Systematic Review: Adjuvant Chemotherapy for Locally Advanced Rectal Cancer with respect to Stage of Disease. Int Sch Res Notices (2015) 0.75
The accuracy and completeness for receipt of colorectal cancer care using Veterans Health Administration administrative data. BMC Health Serv Res (2016) 0.75
Adjuvant and neoadjuvant treatment for rectal cancer, colon cancer, and non-small-cell lung cancer in older patients. Curr Oncol (2014) 0.75
Dosimetric comparative study of 3 different postoperative radiotherapy techniques (3D-CRT, IMRT, and RapidArc) for II-III stage rectal cancer. Medicine (Baltimore) (2015) 0.75
Oncologic Outcomes and Risk Factors for Recurrence after Tumor-specific Mesorectal Excision of Rectal Cancer: 782 Cases. J Korean Soc Coloproctol (2012) 0.75
Unusual Local Recurrence with Distant Metastasis after Successful Endoscopic Submucosal Dissection for Colorectal Mucosal Cancer. Clin Endosc (2016) 0.75
Identification of locally advanced rectal cancer with low risk of local recurrence. PLoS One (2015) 0.75
Long-Term Survival and Local Relapse Following Surgery Without Radiotherapy for Locally Advanced Upper Rectal Cancer: An International Multi-Institutional Study. Medicine (Baltimore) (2016) 0.75
Second-look surgery following Hartmann's procedure for obstructive left-sided colorectal cancer. Oncol Lett (2016) 0.75
Laparoscopic TME associated with neoadjuvant chemoradiation towards aggressive colorectal cancer. Int J Clin Exp Med (2015) 0.75
A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute. Int J Clin Oncol (2015) 0.75
Implementation of a performance improvement initiative in colorectal cancer care. J Oncol Pract (2012) 0.75
KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis. Oncotarget (2017) 0.75
Eastern Canadian Colorectal Cancer Consensus Conference 2013: emerging therapies in the treatment of pancreatic, rectal, and colorectal cancers. Curr Oncol (2016) 0.75
Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). Ann Gastroenterol (2016) 0.75
Trends in surveillance for resected colorectal cancer, 2001-2009. Cancer (2015) 0.75
Association of Poor Differentiation or Positive Vertical Margin with Residual Disease in Patients with Subsequent Colectomy after Complete Macroscopic Endoscopic Resection of Early Colorectal Cancer. Gastroenterol Res Pract (2017) 0.75
Long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision of mid-low rectal cancer following neoadjuvant chemoradiation therapy. Surg Endosc (2016) 0.75
Role of (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Newly Found Suspected Malignant Solitary Pulmonary Lesions in Patients Who Have Received Curative Treatment for Colorectal Cancer. Gastroenterol Res Pract (2017) 0.75
Choosing wisely in cancer control across Canada-a set of baseline indicators. Curr Oncol (2017) 0.75
Delayed versus immediate surgery following short-course neoadjuvant radiotherapy in resectable (T3N0/N+) rectal cancer. J Cancer Res Clin Oncol (2017) 0.75
Endorectal ultrasound does not reliably identify patients with uT3 rectal cancer who can avoid neoadjuvant chemoradiotherapy. Int J Colorectal Dis (2013) 0.75
A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med (2004) 19.45
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol (2007) 11.77
Circulating mutant DNA to assess tumor dynamics. Nat Med (2007) 10.33
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science (2011) 10.26
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med (2004) 9.80
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol (2005) 8.56
Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med (2014) 8.36
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg (2006) 7.18
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol (2008) 7.01
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. J Clin Oncol (2008) 5.78
Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst (2007) 5.48
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol (2011) 5.43
A retrograde-viewing device improves detection of adenomas in the colon: a prospective efficacy evaluation (with videos). Gastrointest Endosc (2009) 5.38
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc (2015) 4.70
Methods for the synthesis of qualitative research: a critical review. BMC Med Res Methodol (2009) 4.69
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA (2008) 4.61
Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2014) 4.61
Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol (2014) 4.59
Containing HIV/AIDS in India: the unfinished agenda. Lancet Infect Dis (2006) 4.58
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J Clin Oncol (2009) 4.54
NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw (2009) 4.41
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet (2011) 4.38
The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One (2008) 4.32
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol (2006) 4.27
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2005) 4.10
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology (2007) 3.99
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol (2005) 3.83
NCCN Task Force Report: Oral chemotherapy. J Natl Compr Canc Netw (2008) 3.82
Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg (2007) 3.73
Prevalence of missed adenomas in patients with inadequate bowel preparation on screening colonoscopy. Gastrointest Endosc (2012) 3.69
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology (2009) 3.57
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology (2008) 3.52
Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A (2011) 3.51
A systematic review of barriers to and facilitators of the use of evidence by policymakers. BMC Health Serv Res (2014) 3.49
WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature (2005) 3.44
Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival. J Clin Oncol (2009) 3.43
Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery (2007) 3.42
RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature (2012) 3.40
Gallbladder cancer: the role of laparoscopy and radical resection. Ann Surg (2007) 3.38
Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors. J Clin Oncol (2012) 3.36
Activity of sunitinib in patients with advanced neuroendocrine tumors. J Clin Oncol (2008) 3.34
Phase II study of erlotinib in patients with advanced biliary cancer. J Clin Oncol (2006) 3.31
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol (2003) 3.31
NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw (2009) 3.25
Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study. J Clin Oncol (2002) 3.25
American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. J Clin Oncol (2014) 3.20
Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2009) 3.17
Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg (2009) 3.15
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist (2011) 3.05
Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2013) 3.03
Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence. Ann Intern Med (2003) 3.01
Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin (2012) 3.01
Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci U S A (2010) 2.87
Colorectal cancer: a tale of two sides or a continuum? Gut (2012) 2.85
Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA (2007) 2.84
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors. J Clin Oncol (2006) 2.80
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg (2015) 2.79
NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw (2009) 2.78